HUSSAIN IQBAL J
Insider CIK 1862050 · CNTA General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 166,779 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 221,559 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 100,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 160,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 100,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 170,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 175,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 160,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer | 2026-06-24 | 2026-06-24 | 5,500 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer | 2026-06-24 | 2026-06-24 | 117,645 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2026-02-02 | 2026-02-03 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-02-02 | 2026-02-03 | 38,951 | $25.15 | $979.6K | 57,645 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2026-02-02 | 2026-02-03 | 40,000 | — | $0 | 97,645 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2026-02-02 | 2026-02-03 | 20,000 | — | $0 | 117,645 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2026-02-01 | 2026-02-03 | 7,780 | $24.57 | $191.2K | 96,596 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-01-30 | 2026-02-03 | 1,010 | $25.01 | $25.3K | 104,376 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-11-17 | 2025-11-18 | 6,000 | — | $0 | 221,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-11-17 | 2025-11-18 | 6,000 | $27.64 | $165.8K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-11-17 | 2025-11-18 | 6,000 | $5.84 | $35.0K | 111,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-10-15 | 2025-10-16 | 6,000 | — | $0 | 227,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-10-15 | 2025-10-16 | 6,000 | $22.41 | $134.5K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-10-15 | 2025-10-16 | 6,000 | $5.84 | $35.0K | 111,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-09-15 | 2025-09-15 | 6,000 | — | $0 | 233,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-09-15 | 2025-09-15 | 6,000 | $21.85 | $131.1K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-09-15 | 2025-09-15 | 6,000 | $5.84 | $35.0K | 111,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-09-10 | 2025-09-11 | 20,000 | — | $0 | 239,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-09-10 | 2025-09-11 | 20,000 | $5.84 | $116.8K | 125,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-09-10 | 2025-09-11 | 20,000 | $22.00 | $440.0K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-09-09 | 2025-09-11 | 20,000 | — | $0 | 259,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-09-09 | 2025-09-11 | 20,000 | $20.01 | $400.2K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-09-09 | 2025-09-11 | 20,000 | $5.84 | $116.8K | 125,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-08-15 | 2025-08-15 | 6,000 | — | $0 | 279,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-08-15 | 2025-08-15 | 6,000 | $5.84 | $35.0K | 111,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-08-15 | 2025-08-15 | 6,000 | $17.23 | $103.4K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-07-15 | 2025-07-17 | 6,000 | — | $0 | 285,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-07-15 | 2025-07-17 | 6,000 | $14.93 | $89.6K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-07-15 | 2025-07-17 | 6,000 | $5.84 | $35.0K | 111,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-06-24 | 2025-06-25 | 12,000 | — | $0 | 291,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-06-24 | 2025-06-25 | 12,000 | $5.84 | $70.1K | 117,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-06-24 | 2025-06-25 | 12,000 | $14.02 | $168.2K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-05-01 | 2025-05-02 | 311 | — | $0 | 303,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-05-01 | 2025-05-02 | 311 | $5.84 | $1.8K | 105,697 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-05-01 | 2025-05-02 | 311 | $14.00 | $4.4K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-04-28 | 2025-04-29 | 2,080 | — | $0 | 303,870 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-04-28 | 2025-04-29 | 2,080 | $5.84 | $12.1K | 107,466 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-04-28 | 2025-04-29 | 2,080 | $14.01 | $29.1K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-04-25 | 2025-04-29 | 3,609 | — | $0 | 305,950 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-04-25 | 2025-04-29 | 3,609 | $5.84 | $21.1K | 108,995 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-04-25 | 2025-04-29 | 3,609 | $14.00 | $50.5K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-03-17 | 2025-03-19 | 6,000 | — | $0 | 309,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-03-17 | 2025-03-19 | 6,000 | $16.45 | $98.7K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-03-17 | 2025-03-19 | 6,000 | $5.84 | $35.0K | 111,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-02-18 | 2025-02-19 | 6,000 | — | $0 | 315,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-02-18 | 2025-02-19 | 1,388 | $17.05 | $23.7K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-02-18 | 2025-02-19 | 6,000 | $5.84 | $35.0K | 111,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-02-18 | 2025-02-19 | 4,612 | $15.91 | $73.4K | 106,774 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2025-02-03 | 2025-02-04 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2025-02-01 | 2025-02-04 | 12,879 | $16.92 | $217.9K | 105,386 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-01-15 | 2025-01-17 | 6,000 | — | $0 | 321,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-01-15 | 2025-01-17 | 6,000 | $15.29 | $91.7K | 118,265 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-01-15 | 2025-01-17 | 6,000 | $5.84 | $35.0K | 124,265 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-12-31 | 2024-12-31 | 7,520 | $16.35 | $123.0K | 118,265 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-12-16 | 2024-12-17 | 6,000 | — | $0 | 327,559 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-12-16 | 2024-12-17 | 6,000 | $5.84 | $35.0K | 203,490 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-12-16 | 2024-12-17 | 77,705 | $16.39 | $1.27M | 125,785 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-09-30 | 2024-10-02 | 7,520 | $15.79 | $118.7K | 197,490 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-06-30 | 2024-07-02 | 7,520 | $9.03 | $67.9K | 205,010 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-03-31 | 2024-04-02 | 7,520 | $11.30 | $85.0K | 212,530 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2024-02-01 | 2024-02-02 | 170,000 | — | $0 | 170,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-02-01 | 2024-02-02 | 7,885 | $8.19 | $64.6K | 220,050 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2024-02-01 | 2024-02-02 | 42,500 | — | $0 | 227,935 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-12-31 | 2024-01-02 | 7,520 | $7.96 | $59.9K | 185,435 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-09-30 | 2023-10-03 | 7,520 | $6.47 | $48.7K | 192,955 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-06-30 | 2023-07-03 | 7,104 | $5.90 | $41.9K | 200,475 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-03-31 | 2023-04-04 | 7,080 | $3.90 | $27.6K | 207,579 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2023-02-01 | 2023-02-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2023-02-01 | 2023-02-03 | 67,100 | — | $0 | 214,659 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2022-12-31 | 2023-01-04 | 3,996 | $3.10 | $12.4K | 159,004 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2022-10-03 | 2022-10-04 | 4,563 | $3.95 | $18.0K | 154,712 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2022-09-30 | 2023-01-13 | 11,445 | $4.25 | $48.6K | 151,555 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2022-09-30 | 2022-10-04 | 3,725 | $4.07 | $15.2K | 159,275 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2022-07-01 | 2022-07-06 | 160,000 | — | $0 | 163,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2022-02-01 | 2022-02-03 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2021-06-02 | 2021-06-04 | 5,500 | $20.00 | $110.0K | 5,500 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2021-06-02 | 2021-06-04 | 3,000 | $20.00 | $60.0K | 3,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2021-05-27 | 2021-06-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2021-04-20 | 2021-06-01 | 166,779 | — | $0 | 166,779 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2021-02-19 | 2021-06-01 | 333,559 | — | $0 | 333,559 | SEC↗ |